Juno Therapeutics Inc JUNO shares are trading up over 22 percent year to date, and the Vetr community has upgraded the company from 4 to 5 stars. Juno stock has steadily risen since the company’s first quarter earnings report showed a 43.48 percent revenue surprise on May 4th.
See how crowd sourced ratings can help predict the market?
Vetr members have given Juno a Strong Buy rating and a $27.99 price target. This price target is lower than the $34.50 price target from Wall Street analysts. The company opened Friday around $24.
Of all Vetr raters, 60 percent believe traders and investors should purchase Juno stock.
For Vetr’s full analysis of Juno, go here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
